pocketful logo light
pocketful logo light
Amrutanjan Health Care Ltd logo

Amrutanjan Health Care Ltd

NSE: AMRUTANJAN BSE: 590006

₹550.50

(1.23%)

Mon, 25 May 2026, 01:36 pm

Amrutanjan Health Care Share Price Live Chart

1 Day

(1.23%)

No Result Found

Summary

  • Market Cap

    1613.79

  • Net Profit

    50.83

  • P/B

    5.61

  • Sector P/E

    45.26

  • P/E

    31.40

  • EV/EBITDA

    15.47

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.95

  • ROCE (Industry)

    16.47

  • RONW (Industry)

    14.44

  • ROE

    20.21

  • ROCE

    31.43

  • Debt/Equity

    0.02

  • EPS (TTM)

    22.31

  • Dividend Yield

    0

  • Book Value

    128.06

  • Interest Cover

    75.30

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (4x coverage).
  • Dividends per share have been stable in the past 10 years.
  • Amrutanjan Health Care is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Amrutanjan Health Care is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Amrutanjan Health Care's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Amrutanjan Health Care's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • Amrutanjan Health Care is not covered by any analysts.
  • Amrutanjan Health Care has significant price volatility in the past 3 months.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters46.5246.5246.5246.5246.52
FII2.172.272.382.412.30
DII12.6613.0012.9012.7011.41
Public38.6538.2138.2038.3739.78
Government00000

Read More

Technical Analysis

RSI

52.60

MACD

1.22

50 DMA

544.41

200 DMA

643.87

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic746.98648.23609.72549.48510.97450.73351.98
Fibonacci648.23610.51587.21549.48511.76488.46450.73
Camarilla598.36589.30580.25549.48562.15553.10544.04

Pivots Level: Classic

R3

+197.50

746.98

R2

+98.75

648.23

R1

+60.23

609.72

549.48
549.48
Pivot Point
LTP: 562.85

S1

-38.52

510.97

S2

-98.75

450.73

S3

-197.50

351.98

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    558.07

  • 20-EMA

    557.52

  • 30-EMA

    556.85

  • 50-EMA

    560.75

  • 100-EMA

    583.39

  • 200-EMA

    619.27

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
08 May 2026board-meetingsAccounts, Final Dividend
03 Feb 2026dividend₹1.00 Dividend /Share07 Feb 2026
03 Feb 2026board-meetingsQuarterly Results, Interim Dividend
07 Jan 2026dividendInterim Dividend - Rs. - 107 Feb 2026
06 Jan 2026dividendInterim Dividend - Re 1 Per Share07 Feb 2026
10 Nov 2025dividend₹1.00 Dividend /Share18 Nov 2025
18 Oct 2025dividendInterim Dividend - Rs. - 118 Nov 2025
16 Aug 2025dividendFinal Dividend - Rs. - 2.616 Sept 2025
12 Aug 2025agm
15 May 2025dividend₹2.60 Dividend /Share16 Sept 2025

Read More

Peer Comparison

Amrutanjan Health Care Ltd logo

Amrutanjan Health Care Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Amrutanjan Health Care Ltd About

Amrutanjan Health Care is engaged in the business of manufacture, supply, sale of products in pain management, congestion management, beverages and hygiene and services in pain management.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1936

Headquarters

CEO

S Sambhuprasad

Employees

Contact

Website icon

Website

http://www.amrutanjan.com

Email icon

Email

investors@amrutanjan.com; customercare@amrutanjan.

Phone icon

Phone

91-44-24994164/24994465/24994366

Location icon

Location

New 103 Old 42-45 LuzChurch Rd, Mylapore, Chennai, Tamil Nadu, 600004

Read More

Amrutanjan Health Care Ltd Company History

YearHistory
No Result Found

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
SUNDARAM MUTUAL FUNDbulkSell21350070013 Jan 2025
NAGESWARAMMA PRIVATE TRUSTbulkSell340275745.2927 Sept 2024
ICICI PRUDENTIAL MUTUAL FUNDbulkBuy65000076026 Sept 2024
NAGESWARAMMA PRIVATE TRUSTbulkSell832725760.0826 Sept 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell191539737.8630 Jun 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy191539737.2130 Jun 2023
N.K.SECURITIESbulkSell371237385.3310 Jun 2020
GRAVITON RESEARCH CAPITAL LLPbulkBuy152024391.1610 Jun 2020
N.K.SECURITIESbulkBuy371237384.9710 Jun 2020
GRAVITON RESEARCH CAPITAL LLPbulkSell152024391.5210 Jun 2020

Read More

Amrutanjan Health Care Ltd News

Amrutanjan Health Care Initiates Postal Ballot for Director Appointments

Amrutanjan Health Care has issued a postal ballot notice seeking shareholder approval for appointment and re-appointment of two Independent Directors via remote e-voting.

18 May 2026

companies

Amrutanjan FY26 PAT Rises 14%; Board Recommends Dividend

Amrutanjan Health Care reported FY26 PAT of INR 5,791.78 lakhs, revenue of INR 50,255.27 lakhs, Q4 EBITDA margin of 19.12%, and recommended a final dividend of INR 2.90 per share.

14 May 2026

companies

Amrutanjan FY26 PAT at INR 5,791.78 Lakhs; Operating Profits Rise 34%

Amrutanjan Health Care reported FY26 PAT of INR 5,791.78 lakhs, revenue from operations of INR 50,255.27 lakhs, and recommended a final dividend of INR 2.90 per share.

13 May 2026

companies

Amrutanjan Q4 FY26: Revenue 1.5B, EBITDA Margin 17.05%

Amrutanjan Health Care Q4 FY26: Revenue 1.5B Rupees vs 1.35B YoY, EBITDA 255M vs 177M YoY, EBITDA margin 17.05% vs 13.07% YoY, net profit 161M vs 152M YoY.

11 May 2026

companies

Amrutanjan FY26 PAT at INR 5,791.78 Lakhs; Board Appoints Directors

Amrutanjan Health Care reported FY26 PAT of INR 5,791.78 lakhs, revenue of INR 50,255.27 lakhs, operating profits up 34%, with new product launches and board director appointments.

09 May 2026

companies

Read More